Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07561827 · ClinicalTrials.gov registry record · Phase 3
The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery
A Phase 3 study, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 42
- Enrollment target
NCT07561827 is a Phase 3 study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 42 participants.
The verdict
NCT07561827, a Phase 3 study, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 42 participants
- Enrollment target
Study Summary
This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery. The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.
Interventions
- DRUG Ropivacaine Hydrocloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2027-01-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07561827
The ClinicalTrials.gov registry entry for NCT07561827 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ropivacaine Hydrocloride is the first listed.
NCT07561827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07561827 about?
NCT07561827 is a clinical study titled "The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery". This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB le...
What is the current status of trial NCT07561827?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 42 participants. The study started on 2025-06-06. Estimated completion is 2027-01-26.
What interventions are being tested in trial NCT07561827?
The interventions under investigation include: Ropivacaine Hydrocloride (DRUG).
Who is sponsoring clinical trial NCT07561827?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.